Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.
|9M 2017 Financial Results reporting||24 October 2017|
|FY 2017 Financial Results reporting||6 February 2018|
|Annual General Meeting of Shareholders||24 April 2018|
Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.
Idorsia is active on social media – follow our channels to get a more personal view on the company.
Idorsia provides images, fact sheets and B-roll to download o support you with your article.